These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 12114746

  • 41. Temporal trends and clinical correlates for the ret/PTC1 mutation in papillary thyroid carcinoma.
    Burgess JR, Skabo S, McArdle K, Tucker P.
    ANZ J Surg; 2003; 73(1-2):31-5. PubMed ID: 12534735
    [Abstract] [Full Text] [Related]

  • 42. RET rearrangements in radiation-induced papillary thyroid carcinomas: high prevalence of topoisomerase I sites at breakpoints and microhomology-mediated end joining in ELE1 and RET chimeric genes.
    Klugbauer S, Pfeiffer P, Gassenhuber H, Beimfohr C, Rabes HM.
    Genomics; 2001 Apr 15; 73(2):149-60. PubMed ID: 11318605
    [Abstract] [Full Text] [Related]

  • 43. Breakpoint characterization of the ret/PTC oncogene in human papillary thyroid carcinoma.
    Smanik PA, Furminger TL, Mazzaferri EL, Jhiang SM.
    Hum Mol Genet; 1995 Dec 15; 4(12):2313-8. PubMed ID: 8634704
    [Abstract] [Full Text] [Related]

  • 44. Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.
    Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A.
    Oncogene; 1994 Feb 15; 9(2):509-16. PubMed ID: 8290261
    [Abstract] [Full Text] [Related]

  • 45. Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.
    Zhu Z, Ciampi R, Nikiforova MN, Gandhi M, Nikiforov YE.
    J Clin Endocrinol Metab; 2006 Sep 15; 91(9):3603-10. PubMed ID: 16772343
    [Abstract] [Full Text] [Related]

  • 46. Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.
    Lanzi C, Borrello MG, Bongarzone I, Migliazza A, Fusco A, Grieco M, Santoro M, Gambetta RA, Zunino F, Della Porta G.
    Oncogene; 1992 Nov 15; 7(11):2189-94. PubMed ID: 1437145
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. RET/PTC (rearranged in transformation/papillary thyroid carcinomas) tyrosine kinase phosphorylates and activates phosphoinositide-dependent kinase 1 (PDK1): an alternative phosphatidylinositol 3-kinase-independent pathway to activate PDK1.
    Kim DW, Hwang JH, Suh JM, Kim H, Song JH, Hwang ES, Hwang IY, Park KC, Chung HK, Kim JM, Park J, Hemmings BA, Shong M.
    Mol Endocrinol; 2003 Jul 15; 17(7):1382-94. PubMed ID: 12738763
    [Abstract] [Full Text] [Related]

  • 50. Gene rearrangements in radiation-induced thyroid carcinogenesis.
    Rabes HM.
    Med Pediatr Oncol; 2001 May 15; 36(5):574-82. PubMed ID: 11340615
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma.
    Basolo F, Giannini R, Monaco C, Melillo RM, Carlomagno F, Pancrazi M, Salvatore G, Chiappetta G, Pacini F, Elisei R, Miccoli P, Pinchera A, Fusco A, Santoro M.
    Am J Pathol; 2002 Jan 15; 160(1):247-54. PubMed ID: 11786418
    [Abstract] [Full Text] [Related]

  • 53. Low prevalence of the ret/PTC3r1 rearrangement in a series of papillary thyroid carcinomas presenting in Belarus ten years post-Chernobyl.
    Pisarchik AV, Ermak G, Demidchik EP, Mikhalevich LS, Kartel NA, Figge J.
    Thyroid; 1998 Nov 15; 8(11):1003-8. PubMed ID: 9848713
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice.
    Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G, Fusco A.
    Oncogene; 1996 Apr 18; 12(8):1821-6. PubMed ID: 8622903
    [Abstract] [Full Text] [Related]

  • 56. Molecular analysis of new subtypes of ELE/RET rearrangements, their reciprocal transcripts and breakpoints in papillary thyroid carcinomas of children after Chernobyl.
    Klugbauer S, Demidchik EP, Lengfelder E, Rabes HM.
    Oncogene; 1998 Feb 05; 16(5):671-5. PubMed ID: 9482114
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Prognostic significance of RET and NTRK1 rearrangements in sporadic papillary thyroid carcinoma.
    Musholt TJ, Musholt PB, Khaladj N, Schulz D, Scheumann GF, Klempnauer J.
    Surgery; 2000 Dec 05; 128(6):984-93. PubMed ID: 11114633
    [Abstract] [Full Text] [Related]

  • 60. The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus.
    Pisarchik AV, Ermak G, Fomicheva V, Kartel NA, Figge J.
    Thyroid; 1998 Feb 05; 8(2):133-9. PubMed ID: 9510121
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.